[go: up one dir, main page]

Abbaraju et al., 2018 - Google Patents

Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses

Abbaraju et al., 2018

Document ID
4711037348515687158
Author
Abbaraju P
Jambhrunkar M
Yang Y
Liu Y
Lu Y
Yu C
Publication year
Publication venue
Chemical Communications

External Links

Snippet

Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC00327K Royal Society of Chemistry View PDF VersionPrevious ArticleNext Article Check for updates …
Continue reading at pubs.rsc.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Similar Documents

Publication Publication Date Title
Abbaraju et al. Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses
Jiang et al. Turning the old adjuvant from gel to nanoparticles to amplify CD8+ T cell responses
Nguyen et al. Mesoporous silica as a versatile platform for cancer immunotherapy
Zhao et al. The application of self-assembled nanostructures in peptide-based subunit vaccine development
CN112672763B (en) Compositions and methods for metal-containing formulations capable of modulating immune responses
Zhang et al. Metal‐organic‐framework‐based vaccine platforms for enhanced systemic immune and memory response
CN105126115B (en) Silica nanoparticles and their use for vaccination
Shi et al. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine
Wang et al. Rod-scale design strategies for immune-targeted delivery system toward cancer immunotherapy
US8642258B2 (en) Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica
US20120189700A1 (en) Nanoparticle Based Immunological Stimulation
Pena et al. Metal–organic coordination polymers for delivery of immunomodulatory agents, and infectious disease and cancer vaccines
de Pádua Oliveira et al. Mesoporous silica nanoparticles as a potential vaccine adjuvant against Schistosoma mansoni
Song et al. Recent advances in particulate adjuvants for cancer vaccination
CN111093623A (en) Pharmaceutical composition, preparation method using lipid vesicle particles of defined size and use thereof
Lacasta et al. Synergistic effect of two nanotechnologies enhances the protective capacity of the Theileria parva sporozoite p67C antigen in cattle
JP2023545466A (en) Crystal polymorphs of STING agonists associated with metal ions that can modulate immune responses
Jambhrunkar et al. Pristine mesoporous carbon hollow spheres as safe adjuvants induce excellent Th2-biased immune response
Powell et al. Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo
Bo et al. Materials‐based vaccines for infectious diseases
Ramirez et al. Co‐delivery of multiple toll‐like receptor agonists and avian influenza hemagglutinin on protein nanoparticles enhances vaccine immunogenicity and efficacy
JP2018529684A (en) Antimalarial compositions and methods
CN104383533A (en) Application of cationic polymer to prepare nanometer immunologic adjuvant and preparation method
Wang et al. Simple synthesis route of mesoporous AlOOH nanofibers to enhance immune responses
Zhang et al. Polymer–Protein Nanovaccine Synthesized via Reactive Self‐Assembly with Potential Application in Cancer Immunotherapy: Physicochemical and Biological Characterization In Vitro and In Vivo